Multiple Myeloma Plasma

In Stock Samples

Lot # Condition Volume Race/Ethnicity Age Gender Country of Collection Medications Vials Price Action
77844 Multiple Myeloma 1.0 ML Hispanic/Latino 80 Female 16 $667.00
77844 Multiple Myeloma 1.0 ML Hispanic/Latino 80 Female 1 $667.00
78637 Multiple Myeloma 1.0 ML 77 Female Ukraine
Acetylsalicylic acid
1 $667.00
78629 Multiple Myeloma 1.0 ML 77 Female Ukraine
Acetylsalicylic acid
1 $667.00
78630 Multiple Myeloma 1.0 ML 77 Female Ukraine
Acetylsalicylic acid
1 $667.00
78631 Multiple Myeloma 1.0 ML 77 Female Ukraine
Acetylsalicylic acid
1 $667.00
78632 Multiple Myeloma 1.0 ML 77 Female Ukraine
Acetylsalicylic acid
1 $667.00
78633 Multiple Myeloma 1.0 ML 77 Female Ukraine
Acetylsalicylic acid
1 $667.00
78634 Multiple Myeloma 1.0 ML 77 Female Ukraine
Acetylsalicylic acid
1 $667.00
78635 Multiple Myeloma 1.0 ML 77 Female Ukraine
Acetylsalicylic acid
1 $667.00

Multiple Myeloma Plasma | High-Quality Human Plasma from Multiple Myeloma Donors

Multiple Myeloma Plasma is collected from donors clinically diagnosed with multiple myeloma and processed within hours of collection to preserve key analytes such as cytokines, proteins, and metabolites. This human plasma supports research focused on biomarker discovery in multiple myeloma pathophysiology.

Product Features

  • Research Use Only (RUO)
  • Plasma collected from clinically confirmed multiple myeloma donors
  • Processed within one day of collection
  • IRB-approved protocols and informed consent
  • Custom aliquot volumes available upon request

De-identified Donor Data

  • Verified multiple myeloma diagnosis
  • Demographic data: age, sex assigned at birth, race/ethnicity
  • Donor-reported medications, allergies, and comorbidities
  • Additional multiple myeloma-specific metadata available

Applications

  • Biomarker discovery and validation
  • Cytokine and inflammation profiling
  • Metabolomics and proteomics studies
  • Therapeutic response research

Compliance and Quality Assurance

  • IRB-approved and HIPAA-compliant protocols
  • Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
  • Documentation support available for regulatory review

Ordering and Customization

Multiple Myeloma plasma is available in standard and custom volumes. For international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations.

Protocols & Documentation

  • Plasma Isolation

    Protocol for plasma separation from anticoagulated whole blood, including processing, storage, and traceability requirements.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

Plasma

Frequently Asked Questions

Showing 1–12 of 31 results

Are samples IRB approved?

1 Answer

YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.

YES – all our products are research use only (RUO).

Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.

Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.

Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.

Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.

YES – we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.

Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.

YES – Unique donors can be specified and guaranteed based on your requirements.

For information about sample quality, please see: Quality and Compliance

YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.

1
×

Ask a Question

Need a custom Plasma cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information